Belhaven Biopharma | WebDisclosure

Switch to English

8295	Sociétés
114833	Mots-clés
55274	Articles
62430	Communiqués

Accueil
Sociétés
Belhaven Biopharma

BRÈVE

publiée le 09/07/2024 à 17:05, il y a 4 mois 11 jours

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
BRÈVE

publiée le 09/07/2024 à 17:05, il y a 4 mois 11 jours

L'étude Belhaven Biopharma montre des résultats prometteurs pour l'administration nasale d'épinéphrine

Belhaven Biopharma Nasdepi Recherche Médicale Traitement De L'anaphylaxie Épinéphrine Nasale
COMMUNIQUÉ DE PRESSE

publié le 09/07/2024 à 17:00, il y a 4 mois 11 jours

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
COMMUNIQUÉ DE PRESSE

publié le 08/02/2024 à 18:30, il y a 9 mois 12 jours

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
COMMUNIQUÉ DE PRESSE

publié le 28/11/2023 à 19:30, il y a 11 mois 22 jours

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Les Echos

Publié le 21/11/2024 à 06:58, il y a 3 heures 58 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 58 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 3 heures 58 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 14 heures 48 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 15 heures 36 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 10:03, il y a 53 minutes

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Publié le 21/11/2024 à 10:00, il y a 56 minutes

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Publié le 21/11/2024 à 09:00, il y a 1 heure 56 minutes

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Publié le 21/11/2024 à 00:35, il y a 10 heures 21 minutes

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Publié le 21/11/2024 à 00:25, il y a 10 heures 31 minutes

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 10:30, il y a 26 minutes

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Publié le 21/11/2024 à 10:04, il y a 51 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:02, il y a 54 minutes

Supervisory Board appoints Carsten Schmitt as new CFO
Publié le 21/11/2024 à 10:00, il y a 56 minutes

Nabaltec AG continues solid earnings performance in third quarter of 2024
Publié le 21/11/2024 à 10:00, il y a 56 minutes

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV